TG Therapeutics, Inc. (TGTX)
46.64
+3.26
(+7.53%)
USD |
NASDAQ |
Jun 10, 16:00
46.51
-0.12
(-0.27%)
After-Hours: 19:58
TG Therapeutics EPS Diluted (TTM) : 2.870 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.870 |
| December 31, 2025 | 2.777 |
| September 30, 2025 | 2.778 |
| June 30, 2025 | 0.3742 |
| March 31, 2025 | 0.244 |
| December 31, 2024 | 0.1397 |
| September 30, 2024 | -0.1067 |
| June 30, 2024 | 0.6001 |
| March 31, 2024 | 0.2204 |
| December 31, 2023 | 0.014 |
| September 30, 2023 | -0.2717 |
| June 30, 2023 | -1.267 |
| March 31, 2023 | -1.231 |
| December 31, 2022 | -1.465 |
| September 30, 2022 | -1.783 |
| June 30, 2022 | -2.165 |
| March 31, 2022 | -2.459 |
| December 31, 2021 | -2.633 |
| September 30, 2021 | -2.639 |
| June 30, 2021 | -2.724 |
| March 31, 2021 | -2.600 |
| December 31, 2020 | -2.398 |
| September 30, 2020 | -2.100 |
| June 30, 2020 | -2.060 |
| March 31, 2020 | -2.006 |
| Date | Value |
|---|---|
| December 31, 2019 | -1.955 |
| September 30, 2019 | -2.183 |
| June 30, 2019 | -1.926 |
| March 31, 2019 | -2.104 |
| December 31, 2018 | -2.258 |
| September 30, 2018 | -2.076 |
| June 30, 2018 | -2.122 |
| March 31, 2018 | -1.976 |
| December 31, 2017 | -1.910 |
| September 30, 2017 | -1.930 |
| June 30, 2017 | -1.950 |
| March 31, 2017 | -1.832 |
| December 31, 2016 | -1.59 |
| September 30, 2016 | -1.48 |
| June 30, 2016 | -1.26 |
| March 31, 2016 | -1.31 |
| December 31, 2015 | -1.38 |
| September 30, 2015 | -1.49 |
| June 30, 2015 | -1.72 |
| March 31, 2015 | -1.70 |
| December 31, 2014 | -1.60 |
| September 30, 2014 | -1.31 |
| June 30, 2014 | -0.96 |
| March 31, 2014 | -0.89 |
| December 31, 2013 | -0.81 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Krystal Biotech, Inc. | 7.482 |
| MAIA Biotechnology, Inc. | -0.6796 |
| Vericel Corp. | 0.4091 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| United Therapeutics Corp. | 27.09 |